Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT03331601

Evaluation of 68-GaNOTA-Anti-HER2 VHH1 Uptake in Brain Metastasis of Cancer Patients

Led by Universitair Ziekenhuis Brussel · Updated on 2024-04-24

30

Participants Needed

1

Research Sites

476 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study investigates the uptake of the radiopharmaceutical 68-GaNOTA-Anti-HER2 VHH1 in brain metastasis using PET/CT imaging. Patients with HER2-positive and HER2-negative cancer will be included and the uptake in their lesions will be compared. Optional 68-GaNOTA-Anti-HER2 VHH1 scans may be performed during or after treatment, at time points 12±6 weeks and 24±9 weeks after the first scan.

CONDITIONS

Official Title

Evaluation of 68-GaNOTA-Anti-HER2 VHH1 Uptake in Brain Metastasis of Cancer Patients

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients who have given informed consent
  • Age 18 years or older
  • Patients with brain metastasized cancer, with at least 1 brain lesion of at least 8 mm maximal diameter, as measured by CT or MRI
  • Patients with potentially HER2-positive cancer, either with prior HER2 staining or sufficient tissue available for HER2 staining for study purposes
Not Eligible

You will not qualify if you...

  • Pregnant patients
  • Breastfeeding patients
  • Patients with recent (less than 1 week) gastrointestinal disorders with diarrhea as the major symptom
  • Patients with any serious active infection
  • Patients with any other life-threatening illness or organ system dysfunction that could compromise safety or interfere with evaluation
  • Patients unable to communicate reliably with the investigator
  • Patients at increased risk of death from a pre-existing concurrent illness

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Uz Brussel

Brussels, Belgium, 1090

Actively Recruiting

Loading map...

Research Team

U

UZ Brussel

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here